I'm sorry Moreforme but T2D is one indication where we're not going to see any major announcements from MSB after the disappointing Phase 2 results. Do the research yourself and compare how MSB's modest improvements compare with other treatments and also take note of how much improvement is considered to be clinically rather than statistically significant - we were only half way there. This is why there has been no suggestion of a phase 3 for T2D only for more research regarding complications associated with it. Who knows maybe multiple regular injections would make a difference but I wouldn't be brimming with overconfidence if I were you.
t2d - very interesting...but, page-2
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |